<DOC>
	<DOCNO>NCT00450437</DOCNO>
	<brief_summary>This study evaluate lot lot consistency , safety immune response Novartis Meningococcal ACWY conjugate vaccine healthy US adolescent adult .</brief_summary>
	<brief_title>A Study Evaluate Safety Immune Response Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Healthy subject 1155 year age inclusive give appropriate write assent and/or consent Subjects previous suspect disease cause N. meningitidis previous immunization meningococcal vaccine vaccine contain meningococcal antigen ( ) previous suspect disease cause N. meningitidis Any serious acute , chronic progressive disease Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>meningitis</keyword>
	<keyword>vaccine</keyword>
	<keyword>adolescent</keyword>
	<keyword>adult</keyword>
</DOC>